Neogen reported $149.5M in Current Liabilities for its fiscal quarter ending in June of 2026.





Current Liabilities Change Date
Agilent USD 2.29B 20M Jun/2026
Bio-Rad Laboratories USD 961.3M 44.3M Jun/2026
Cerus USD 100.8M 12.37M Dec/2025
Danaher USD 9.05B 945M Sep/2026
Idexx Laboratories USD 1.29B 12.19M Jun/2026
Illumina USD 1.58B 12M Jun/2026
Integra LifeSciences USD 329M 1.88M Sep/2026
Neogen USD 149.5M 8.7M Jun/2026
OraSure Technologies USD 25.12M 18.96M Jun/2026
Pacific Biosciences Of California USD 68.81M 3.45M Jun/2026
Quidel USD 993.4M 31M Jun/2026
Rockwell Medical USD 10.95M 259K Jun/2025
STAAR Surgical USD 73.39M 12.4M Jun/2026
Thermo Fisher Scientific USD 14.17B 899M Sep/2026
Utah Medical Products USD 3.5M 907K Mar/2026
Zoetis USD 2.06B 8M Jun/2026